Dung‐Tsa Chen

4.9k total citations
106 papers, 2.9k citations indexed

About

Dung‐Tsa Chen is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dung‐Tsa Chen has authored 106 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Oncology, 38 papers in Molecular Biology and 29 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dung‐Tsa Chen's work include Pancreatic and Hepatic Oncology Research (18 papers), Lung Cancer Treatments and Mutations (15 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Dung‐Tsa Chen is often cited by papers focused on Pancreatic and Hepatic Oncology Research (18 papers), Lung Cancer Treatments and Mutations (15 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Dung‐Tsa Chen collaborates with scholars based in United States, Taiwan and Puerto Rico. Dung‐Tsa Chen's co-authors include Mokenge P. Malafa, Scott Antonia, William J. Fulp, Alberto Chiappori, Dmitry I. Gabrilovich, Cristina Iclozan, Timothy J. Yeatman, Eric B. Haura, Domenico Coppola and Ardeshir Hakam and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Dung‐Tsa Chen

101 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dung‐Tsa Chen United States	28	1.3k	1.2k	684	526	416	106	2.9k
Ioannis S. Pateras Greece	28	1.5k 1.2×	993 0.8×	790 1.2×	568 1.1×	319 0.8×	77	2.8k
Qinglei Gao China	33	2.1k 1.6×	1.0k 0.9×	756 1.1×	569 1.1×	337 0.8×	171	3.7k
Chi‐Long Chen Taiwan	32	1.3k 1.0×	910 0.8×	680 1.0×	342 0.7×	389 0.9×	106	2.9k
Junnian Zheng China	30	1.7k 1.4×	1.1k 1.0×	561 0.8×	492 0.9×	310 0.7×	146	3.0k
Bei Lin China	28	1.7k 1.3×	621 0.5×	728 1.1×	593 1.1×	300 0.7×	156	2.8k
Anamaria A. Camargo Brazil	30	2.4k 1.9×	906 0.8×	759 1.1×	538 1.0×	501 1.2×	128	3.8k
Yi Fang China	28	1.5k 1.2×	691 0.6×	710 1.0×	401 0.8×	303 0.7×	127	3.0k
Cécile Le Page Canada	28	1.2k 1.0×	1.1k 1.0×	567 0.8×	995 1.9×	336 0.8×	62	3.1k
Yongsheng Wang China	27	1.1k 0.9×	1.0k 0.9×	398 0.6×	759 1.4×	590 1.4×	133	2.8k
Jessica Wang‐Rodriguez United States	34	2.0k 1.6×	959 0.8×	894 1.3×	284 0.5×	634 1.5×	96	3.9k

Countries citing papers authored by Dung‐Tsa Chen

Since Specialization

Citations

This map shows the geographic impact of Dung‐Tsa Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dung‐Tsa Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dung‐Tsa Chen more than expected).

Fields of papers citing papers by Dung‐Tsa Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dung‐Tsa Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dung‐Tsa Chen. The network helps show where Dung‐Tsa Chen may publish in the future.

Co-authorship network of co-authors of Dung‐Tsa Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Dung‐Tsa Chen. A scholar is included among the top collaborators of Dung‐Tsa Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dung‐Tsa Chen. Dung‐Tsa Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tarhini, Ahmad A., Sandra J. Lee, William A. LaFramboise, et al.. (2025). Integrative Immune Signature of Complementary Circulating and Tumoral Biomarkers Maximizes the Predictive Power of Adjuvant Immunotherapeutic Benefits in High-risk Melanoma. Clinical Cancer Research. 31(15). 3249–3258.

Jeong, Daniel, Brian Morse, Dung‐Tsa Chen, et al.. (2024). Pancreatic Cyst Size Measurement on Magnetic Resonance Imaging Compared to Pathology. Cancers. 16(1). 206–206. 2 indexed citations

Li, Jiannong, Edna R. Gordián, Steven A. Eschrich, et al.. (2024). Worse Clinical and Survival Outcomes in Breast Cancer Patients Living in Puerto Rico Compared to Hispanics, Non-Hispanic Blacks, and Non-Hispanic Whites from Florida. Journal of Racial and Ethnic Health Disparities. 13(1). 130–140. 1 indexed citations

Sahebjam, Solmaz, et al.. (2024). A sample size analysis of a mathematical model of longitudinal tumor volume and progression‐free survival for Bayesian individual dynamic predictions in recurrent high‐grade glioma. CPT Pharmacometrics & Systems Pharmacology. 14(3). 495–509. 1 indexed citations

Saltos, Andreas, Tawee Tanvetyanon, Ben Creelan, et al.. (2023). Phase II randomized trial of first-line pembrolizumab and vorinostat in patients with metastatic NSCLC (mNSCLC): Final results.. Journal of Clinical Oncology. 41(16_suppl). 9125–9125. 2 indexed citations

Thapa, Ram, Michael Shafique, Andreas Saltos, et al.. (2023). Osimertinib vs. afatinib as first-line treatment for patients with metastatic non-small cell lung cancer with an EGFR exon 19 deletion or exon 21 L858R mutation. Journal of Thoracic Disease. 15(11). 6115–6125. 4 indexed citations

Freeman, Ciara L., Meghan Menges, Jeffrey Edelman, et al.. (2023). Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma. Clinical Cancer Research. 29(22). 4575–4585. 8 indexed citations

Chen, Dung‐Tsa, Andreas Saltos, Trevor Rose, et al.. (2023). Early Adverse Event Derived Biomarkers in Predicting Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy. Cancers. 15(9). 2521–2521. 2 indexed citations

Amorrortu, Rossybelle P., Issam El Naqa, Yoganand Balagurunathan, et al.. (2023). Overview of approaches to estimate real-world disease progression in lung cancer. JNCI Cancer Spectrum. 7(6). 3 indexed citations

10.

Permuth, Jennifer B., Shams Rahman, Dung‐Tsa Chen, Tim Waterboer, & Anna R. Giuliano. (2021). A Case Control Study of the Seroprevalence of Helicobacter pylori Proteins and Their Association with Pancreatic Cancer Risk. SHILAP Revista de lepidopterología. 7(1). 57–64. 7 indexed citations

11.

Chen, Dung‐Tsa, Wenyaw Chan, Zachary Thompson, et al.. (2021). Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer. PLoS ONE. 16(7). e0252041–e0252041. 4 indexed citations

12.

Marchion, Douglas C., Susan McCarthy, Ardeshir Hakam, et al.. (2021). Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes. PLoS ONE. 16(11). e0256615–e0256615. 3 indexed citations

13.

Gray, Jhanelle E., Andreas Saltos, Tawee Tanvetyanon, et al.. (2019). Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non–Small Cell Lung Cancer. Clinical Cancer Research. 25(22). 6623–6632. 104 indexed citations

14.

Gangi, Alexandra, Jennifer Sweeney, Junsung Choi, et al.. (2018). Intrahepatic Cholangiocarcinoma Treated with Transarterial Yttrium-90 Glass Microsphere Radioembolization: Results of a Single Institution Retrospective Study. Journal of Vascular and Interventional Radiology. 29(8). 1101–1108. 56 indexed citations

15.

Luu, Carrie, Ram Thapa, Trevor Rose, et al.. (2018). Identification of nonalcoholic fatty liver disease following pancreatectomy for noninvasive intraductal papillary mucinous neoplasm. International Journal of Surgery. 58. 46–49. 14 indexed citations

16.

Permuth‐Wey, Jennifer, Dung‐Tsa Chen, William J. Fulp, et al.. (2015). Plasma MicroRNAs as Novel Biomarkers for Patients with Intraductal Papillary Mucinous Neoplasms of the Pancreas. Cancer Prevention Research. 8(9). 826–834. 41 indexed citations

17.

Chen, James J., et al.. (2014). Biomarker adaptive designs in clinical trials. Translational Cancer Research. 3(3). 279–292. 19 indexed citations

18.

Yarde, Danielle N., Vasco Oliveira, Linda Mathews, et al.. (2009). Targeting the Fanconi Anemia/BRCA Pathway Circumvents Drug Resistance in Multiple Myeloma. Cancer Research. 69(24). 9367–9375. 90 indexed citations

19.

Chen, Dung‐Tsa, Aejaz Nasir, Aedín C. Culhane, et al.. (2009). Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue. Breast Cancer Research and Treatment. 119(2). 335–346. 115 indexed citations

20.

Chen, Dung‐Tsa, Wenyaw Chan, David J. Francis, Sally E. Shaywitz, & Bennett A. Shaywitz. (2002). APPLICATION OF TWO-LEVEL NEGATIVE EXPONENTIAL MODEL TO CHILDREN'S LEARNING CURVE IN READING. Communications in Statistics - Simulation and Computation. 31(2). 279–299. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact